Arrhythmias & electrophysiology

Quantifying DNA Lesions and Circulating Free DNA: Diagnostic Marker for Electropathology and Clinical Stage of Atrial Fibrillation (AF)

JACC Clin ElectrophysiolPublished High-sensitivity long-run real-time PCR was performed on mitochondrial (ND1) and nuclear (P53) DNA from atrial tissue samples

Authors' conclusion

The quantity of DNA lesions in atrial tissue samples is associated with atrial conduction abnormalities and stage of AF. Serum DNA damage markers discriminate short- from long-term AF. Therefore, the quantity of DNA damage may have diagnostic value in clinical AF management.

Study context

Population
Patients with paroxysmal (PAF), persistent (PeAF), and longstanding persistent (LS-PeAF) AF, and sinus rhythm (SR) patientspatients with atrial tissue samples · blood samples of patients with AF or SR 70 · high-resolution epicardial mapping of the atria 48
Participants
83 patients
Comparison
DNA damage in atrial tissue and blood samples as an indicator of the prevalence of electrical conduction abnormalities and stage of AF
Outcome
Number of DNA lesions
Methodological detailsPicoGreen assay and quantitative polymerase chain reaction on circulating free DNA (cfDNA) markers, High-resolution epicardial mapping of the atria
  • PicoGreen assay and quantitative polymerase chain reaction on circulating free DNA (cfDNA) markers
  • High-resolution epicardial mapping of the atria

Main finding

As reported in the abstract

  • Gradually and significantly increased in PAF and PeAF and in patients with <3 years of AF compared with SR

Further findings

OutcomeP value
Mitochondrial cfDNA levels>3 years of AF vs <3 years of AF · decreased in patients with >3 years of AFP = 0.004

Nuclear DNA damage and fractionated potentials (SR)

In SR, the quantity of nuclear DNA damage significantly correlated with the proportion of fractionated potentials

Mitochondrial DNA lesions and conduction (AF samples)

Mitochondrial DNA lesions correlated with slower conduction velocity and lower potential amplitudes in AF samples

Original publication

Quantifying DNA Lesions and Circulating Free DNA: Diagnostic Marker for Electropathology and Clinical Stage of AF. JACC Clin Electrophysiol. Published 8 January 2025. doi:10.1016/j.jacep.2024.10.008

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.